Disclaimer: The medications discussed in this article may include compounded preparations from a licensed 503A compounding pharmacy. Compounded medications have not been reviewed or approved by the FDA and are not the same as commercially available FDA-approved products. This content is for educational purposes only and does not constitute medical advice or establish a provider-patient relationship. Please consult a licensed healthcare provider for personalized clinical guidance.
The question I hear most often from patients considering a GLP-1 medication is not “will it work?” Most of them have already read enough to believe it will work. The question I hear most is “will I lose muscle?” It is a real concern, and the answer is nuanced in a way that a quick internet search does not capture well. GLP-1 muscle loss is real, but the degree to which it happens depends enormously on what a patient does around the medication, specifically how much protein they eat and whether they are doing resistance training.
What Lean Mass Loss on GLP-1 Therapy Actually Looks Like
A portion of any significant weight loss comes from lean tissue, not just fat. This is true of weight loss by any method: dietary restriction, bariatric surgery, or GLP-1 therapy. In my clinical experience, GLP-1 medications do not independently accelerate muscle loss beyond what losing weight by any means would produce. A meaningful share of weight lost comes from lean tissue when patients do not engage in structured resistance training, with the majority coming from fat.
The problem is not the drug. The problem is that when appetite suppression reduces food intake significantly, protein often falls along with total calories, and lean tissue pays the price. That is the pattern I see repeatedly in patients who lose weight quickly without a deliberate protein and training plan in place.
The patients who do this program right lose fat. The patients who simply inject without adjusting protein intake lose fat and muscle together. There is a meaningful clinical difference in body composition outcomes between those two groups, and the separating variable is not the medication. It is what happens around it.
For patients considering adding sermorelin to their GLP-1 protocol to further support lean mass through the GH/IGF-1 axis, see The Combination We Prescribe When Patients Want to Lose Weight Without Losing Muscle.
The Leucine Threshold and Why Protein Distribution Matters
Understanding why protein distribution across meals matters requires a brief explanation of how muscle protein synthesis actually works at the cellular level. Muscle protein synthesis is regulated in large part through the mTOR pathway, a cellular signaling system that acts as a nutrient sensor and growth regulator. Among the amino acids that activate mTOR, leucine is the most potent trigger. Research has established a leucine threshold: approximately 2.5 to 3 grams of leucine per meal is required to maximally stimulate muscle protein synthesis via mTOR. Below that threshold, the anabolic response is blunted.
The clinical target I set for patients on GLP-1 therapy includes not just a total daily protein number but a per-meal distribution framework: 1.2 to 1.6 grams of protein per kilogram of body weight per day, distributed across at least three meals, with each meal containing a minimum of 30 to 40 grams of high-quality protein.
What I consistently see in practice is that many patients cannot reliably hit these targets once they are well into therapy, because appetite is substantially blunted. One large protein meal at dinner does not produce the same anabolic effect as three meals each crossing the leucine threshold throughout the day. The mTOR signal fires and fades. It needs to be re-triggered at each meal to sustain the rate of muscle protein synthesis that counteracts the catabolic forces of a caloric deficit.
Resistance Training: The Mechanical Signal That Walking Cannot Replace
The second pillar of the protocol is resistance training, and this is where I encounter the most pushback from patients. Patients who are losing weight are often tired, often dealing with nausea at some point in titration, and often inclined to believe that walking or light cardio is sufficient. The biology says otherwise.
Resistance training preserves muscle through a specific biological mechanism: mechanical tension applied to a muscle triggers the activation of satellite cells, the resident stem cells of skeletal muscle tissue. Satellite cells proliferate and fuse with existing muscle fibers, contributing to myofibrillar protein synthesis and structural repair. This mechanical tension signal is distinct from metabolic or hormonal stimuli. It requires that the muscle be loaded near its capacity to generate the cellular response that signals the body to maintain and rebuild fiber density.
Walking does not provide this stimulus at a meaningful level for most patients. Aerobic exercise has well-documented cardiovascular and metabolic benefits, and I want all patients incorporating regular low-intensity movement. But aerobic exercise and resistance training do different things to skeletal muscle biology. During a caloric deficit, when the body’s default tendency is to catabolize protein from muscle to meet energy needs, resistance training sends a countervailing signal: this tissue is being used, do not sacrifice it. Without that signal, the proportion of lean mass lost during weight reduction is higher than it needs to be.
The protocol I recommend is a minimum of two to three resistance training sessions per week, each focusing on compound movements that recruit large muscle groups: squats, deadlifts, presses, rows, and lunges. Patients who do not have gym access or equipment can achieve adequate mechanical stimulus with bodyweight exercises performed to near muscular failure.
Understanding Hair Loss: The Same Upstream Cause
Patients often come to me alarmed about hair shedding during GLP-1 therapy. The clinical term for this phenomenon is telogen effluvium, and understanding the mechanism explains why it shares an upstream cause with lean mass loss.
The hair follicle cycles through growth phases: anagen is the active growth phase, and telogen is the resting phase from which hair sheds. Under normal conditions, approximately 10 to 15 percent of follicles are in the telogen phase at any time. When the body experiences significant physiological stress, including rapid caloric restriction or major nutritional deficits, a larger-than-normal fraction of follicles shift from anagen into telogen simultaneously. The timing of this shift typically lags the stressor by two to three months, which is why patients often notice hair shedding well after the period of most rapid weight loss began.
Patients who maintain adequate protein intake and avoid severe caloric restriction beyond what the medication naturally produces tend to experience less pronounced hair shedding and faster recovery. Both problems have the same upstream solution: protect protein intake and do not compound the medication’s caloric suppression with additional aggressive dieting.
The Full Protocol in Practice
The protocol I give patients starting a GLP-1 has three components. First, a protein target: 1.2 to 1.6 grams per kilogram of body weight per day, distributed across at least three meals, each crossing the leucine threshold with 30 to 40 grams of protein. Second, resistance training: two to three sessions per week, full body, compound movements performed with enough load to generate real mechanical tension. Third, restraint around additional caloric restriction: let the drug do what it does. Stacking an aggressive low-calorie diet on top of a medication that is already reducing intake significantly produces a deficit larger than needed, a protein shortfall more severe, and a lean mass cost higher than necessary.
Patients who follow this framework lose fat and maintain a substantially higher proportion of lean mass than patients who treat the medication as the only variable in the equation.
FAQ
Q: How much muscle loss is normal on a GLP-1 medication? A portion of the weight lost on GLP-1 therapy comes from lean tissue, with the majority coming from fat. This is comparable to what happens with weight loss through dietary restriction alone. The absolute amount of muscle lost depends significantly on protein intake and resistance training during the weight loss period.
Q: Is resistance training necessary, or is cardio sufficient? Cardiovascular exercise has meaningful health benefits, but it does not provide the mechanical stimulus that signals the body to preserve skeletal muscle during a caloric deficit. Resistance training two to three times per week is the clinically supported approach for muscle preservation. Both are beneficial; resistance training is the component that is non-substitutable for this specific goal.
Q: Why do patients experience hair shedding on GLP-1 medications? Hair shedding during GLP-1 therapy is most often telogen effluvium, a temporary shedding caused by the physiological stress of rapid caloric restriction and nutritional changes. It typically appears two to three months after the period of most rapid restriction and is not caused directly by the medication. Maintaining adequate protein intake reduces its severity and duration.
Q: What if appetite suppression makes hitting protein targets difficult? Protein shakes and protein-fortified foods are clinically appropriate tools for patients on GLP-1 therapy who struggle to reach targets through whole food alone. Prioritizing protein at every meal before moving to other macronutrients, and using a high-quality protein supplement for any meal where targets are difficult to meet, are practical strategies used regularly in our practice.
Q: Can muscle lost during the weight loss phase be recovered? Lean mass lost during the weight loss phase can be regained after reaching a stable weight, particularly with continued resistance training and adequate protein intake. Many patients experience meaningful improvements in body composition during a maintenance phase after active weight loss.
Q: How does Precision Telemed’s program support body composition? Precision Telemed providers offer ongoing async follow-up that includes guidance on nutrition and lifestyle practices during GLP-1 therapy. The goal of the program is not just weight reduction but overall metabolic and body composition improvement.
References
- Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(Suppl 4):16-27. doi:10.1111/dom.15728
- Ida S, Kaneko R, Imataka K, et al. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism. 2024. PubMed: 39719170
To speak with one of our licensed providers about whether this is right for you, visit www.precisiontelemed.com.
This article is for educational purposes only and does not constitute medical advice or establish a provider-patient relationship. Compounded medications have not been reviewed by the FDA and are not the same as commercially available FDA-approved products. Please consult your healthcare provider.